跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Keppra - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Keppra
Approved
STANDARD
Keppra
UCB Pharma SA
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9365acb761cc651c
Company
UCB Pharma SA
Type
Standard
Approval Details
Approval Id
9365acb761cc651c
Drug Approval Philippines Name
Keppra
Product Name
Keppra
Registration Number
DR-XY29934
Brand Name
Keppra
Generic Name
Levetiracetam
Dosage Form
Film-Coated Tablet
Dosage Strength
250 mg
Manufacturer
UCB Pharma SA
Importer
GlaxoSmithKline Philippines, Inc.
Company Detail Path
/organization/ucb-pharma-sa
Issuance Date
28 September 2022
Expiry Date
20 November 2027
Pharmacologic Category
Antiepileptics
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9365acb761cc651c
Type
Standard
Back to Philippines FDA Approvals